Naomi Levinthal Joins Reperio Health as Chief Growth Officer

Reperio Health has appointed Naomi Levinthal as chief growth officer, a new role in which she will lead the company’s commercial operations and strategy.

“We’re thrilled to welcome Naomi and bring her impressive set of skills and relationships to our sales, marketing, and customer teams,” Reperio Co-Founder/CEO Travis Rush said. “Staffing shortages, health inequities, and clinician burnout have placed a huge strain on our healthcare system—with many patients and consumers in the dark about their health status. With Naomi on board, we are confident that our solution will reach into every corner of our healthcare industry to influence the future of preventive health and wellness.”
 
With nearly 20 years of experience as a successful business leader, seasoned healthcare IT, and digital health advisor, Levinthal joins Reperio from Memora Health, where she was vice president of Strategy and Partnerships. During her tenure, Levinthal drove significant growth across hospitals and health systems, digital health, and life sciences market segments, and developed valuable commercial partnerships. Previously, she also worked as vice president of Product Strategy and Partnerships with AVIA Health, and managing director at the Advisory Board Company (now Optum).
 
“The Reperio at-home screening kit allows anyone to know their health risks 24/7, and is able to address a number of urgent healthcare needs across our industry,” Levinthal stated. “Reperio can transform wellness programs for employers, provide population health insights for care teams, and expand access to care in retail pharmacies. I am honored to join a company that can positively impact the entire healthcare ecosystem and bring my expertise in building high-performing teams and growing startups.”
 
Earlier this year, Reperio announced its first patent for the technology that powers the company’s biometric home-based screening service. Reperio’s flagship at-home screening kit utilizes multiple U.S. Food and Drug Administration-cleared medical devices in one coordinated end-user experience to measure key health metrics from the comfort of home or at in-person screening events.
 
Reperio takes health screenings out of the lab and delivers instant results at home. Reperio supplies employers and healthcare providers with patented screening kits that pair with a mobile app to assess key health indicators, such as cholesterol, glucose levels and blood pressure, in less than 30 minutes.